TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
active
Official procurement procedure

Provision of Clinical Trial Monitoring to the FaR-RMS Trial

Clinical information system
Design and execution of research and development
Patient-monitoring system
West Midlands (UKG31)
Published value
Not published
Submission deadline 30 Apr 2021, 12:00 BST
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial: "Provision of Clinical Trial Monitoring to the FaR-RMS Trial". Published status: active. Published value: Value not published. 1 published lot. Recorded submission deadline: 30 Apr 2021, 12:00 BST. See the official notice for participation instructions.
Contracting AuthorityTender for the Provision of Clinical Trial Monitoring to the FaR-RMS TrialScope & CategoriesNot publishedSubmission Window
Closed
30 Apr 2021, 12:00 BST
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
Not availableNo published reports
Bid counts are not published for this buyer
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityTender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial
Procedure methodNot published
Procurement categoryNot published
Statusactive
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published31 Mar 2021, 14:30 BST
Last source update31 Mar 2021, 14:30 BST
Recurring procurementNo
ClassificationClinical information system, Design and execution of research and development, Patient-monitoring system
Delivery area
West Midlands (UKG31)
OCIDocds-h6vhtk-02a184
What is being bought
The FaR-RMS trial The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.
What changed
From the official release history
  1. Status changed to active
    31 Mar 2021, 14:30 BST
  2. Official notice release published
    31 Mar 2021, 14:30 BST
  3. Submission deadline changed to 30 Apr 2021, 12:00 BST
    31 Mar 2021, 14:30 BST
  4. Buyer information updated
    31 Mar 2021, 14:30 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    active
    Published valueNot published
    The University of Birmingham Cancer Research Clinical Trials Unit are working on a collaboration with a large Pharmaceutical company to add a new arm to an existing study. The trial is a multicentre, randomised phase II trial evaluating the new therapy against a control arm in paediatric patients with relapsed/refractory rhabdomyosarcoma. Patients will receive therapy for up to 12 cycles (approx. 12 months) and will be followed-up for 5 years.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    31 Mar 2021, 14:30 BST
  2. Submission deadline
    30 Apr 2021, 12:00 BST
Commercial outcome and competition
AwardsNo award published
ContractsNo contract published
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Tender for the Provision of Clinical Trial Monitoring to the FaR-RMS Trial

Contracting authority GB-FTS-10779
View buyer profile
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published